SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-20-176446
Filing Date
2020-06-23
Accepted
2020-06-23 15:17:04
Documents
5
Group Members
AARON GLENN LOUIS FLETCHERBIOS ADVISORS GP, LLCBIOS CAPITAL MANAGEMENT, LPBIOS EQUITY PARTNERS II, LPBIOS FUND I QP, LPBIOS FUND I, LPBIOS FUND II NT, LPBIOS FUND II QP, LPBIOS FUND II, LPBP DIRECTORS, LPCAVU ADVISORS, LLCCAVU MANAGEMENT, LPLESLIE WAYNE K

Document Format Files

Seq Description Document Type Size
1 SC 13D d949930dsc13d.htm SC 13D 426136
2 EX-99.A d949930dex99a.htm EX-99.A 58246
3 EX-99.B d949930dex99b.htm EX-99.B 53996
4 EX-99.I d949930dex99i.htm EX-99.I 56043
5 EX-99.J d949930dex99j.htm EX-99.J 14177
  Complete submission text file 0001193125-20-176446.txt   610651
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Subject) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91536 | Film No.: 20981756
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107 817-381-5370
Bios Equity Partners, LP (Filed by) CIK: 0001813314 (see all company filings)

IRS No.: 822422973 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D